News Sentiment

LIXT sentiment intelligence

Lixte Biotechnology Holdings Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 62 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 7.61 Week of 19 Jun 2026
Weighted tone 55/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 62

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+22.9% over one week, +29.4% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

LIXTE to loan $6.5M to NOMAD ahead of acquisition close

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction 22.9% Price confirming higher
Trend fit Trend active 29.4% over four weeks
Fair value 163.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 18
Neutral 38
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 62
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 13
TradingKey 11
Market source 7
GlobeNewswire 5
Investing.com 4
TradingView 4
simplywall.st 3
NewMediaWire 3

Event Lens

What the news is about

Classified themes
Market update 32
Earnings 17
Deals and strategy 12
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 62
Stock Titan Direct company coverage

Lixte (NASDAQ: LIXT) closes $16.6M registered direct stock sale

Lixte Biotechnology Holdings, Inc. has successfully closed a registered direct offering, raising approximately $16.6 million in gross proceeds. The offering included 2,366,503 shares of common stock and Pre-Funded Warrants for an additional 258,859 shares, priced at $6.31 per sha

Tone
Neutral 50/100
Event
Market update
Published
04 Jun 2026 20:39
Source
Stock Titan
Stock Titan Direct company coverage

Lixte (NASDAQ: LIXT) sells 2.37M shares and 258,859 pre-funded warrants for $16.6M

Lixte Biotechnology Holdings, Inc. (LIXT) is conducting an equity offering of 2,366,503 shares of Common Stock and 258,859 Pre-Funded Warrants at a price of $6.31 each, aiming to raise approximately $16.57 million in gross proceeds. The company plans to use these proceeds for wor

Tone
Neutral 50/100
Event
Market update
Published
04 Jun 2026 20:39
Source
Stock Titan
GlobeNewswire Direct company coverage

LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth

LIXTE Biotechnology Holdings, Inc. announced a registered direct offering of approximately $16.57 million through the sale of common stock and pre-funded warrants. This financing is intended to significantly strengthen the company's balance sheet, provide flexibility for strategi

Tone
Positive 74/100
Event
Market update
Published
04 Jun 2026 04:09
Source
GlobeNewswire